September 22, 2021
Article
Perspective
Takayuki Yoshino, MD, PhD provides perspective on key issues surrounding therapy selection in gastrointestinal cancers.
September 21, 2021
Article
Product Profile
In an interview with ONCOLOGY®, Sandra Cuellar, PharmD, BCOP, FASHP, offers a comprehensive review of real-world treatment considerations of margetuximab as therapy for adult patients with metastatic HER2-positive breast cancer who have received 2 or more prior anti-HER2 regimens with at least 1 being for metastatic disease.
September 20, 2021
Article
Interview
“That’s the beauty of science. Anything can be intellectual.”
September 17, 2021
Article
Editorial
ONCOLOGY® co–editor-in-chief, Julie Vose, discusses how the COVID-19 pandemic has caused physician burnout and what may be done to prevent it.
September 16, 2021
Article
Clinical Quandaries
This clinical quandary discusses oligoprogressive disease in metastatic melanoma and how treatment with immunotherapy and targeted therapy affect the disease.
September 15, 2021
Article
Review Article
Patients with colorectal cancer could benefit from the COLMATE platform as it allows for opportunities in clinical trial enrollment.
September 14, 2021
Article
Original Research
This study investigated the biomarker potential of glutamine among known prognostic variables in localized prostate cancer.